Position in OGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,533
+$1,970 QoQ
Shares Held
261
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#382
of 626 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026City State Bank holds $12,975,121 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,696 | $3,233,663 | |
| 2 | JNJ |
Johnson & Johnson
|
11,234 | $2,853,098 | |
| 3 | ABBV |
AbbVie Inc.
|
9,181 | $2,310,306 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,960 | $1,793,860 | |
| 5 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 6 | PFE |
Pfizer Inc
|
29,095 | $700,607 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,431 | $485,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,212 | $405,804 |
All Filings in OGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,533 | 261 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,563 | 261 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,943 | 271 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,787 | 261 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,526 | 261 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,886 | 261 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,894 | 261 | Shares | Sole | 2025-01-13 | |
| 2023-12-31 | $12,502 | 867 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $16,023 | 923 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $19,478 | 936 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $22,837 | 971 | Shares | Sole | 2023-04-10 | |
| 2021-12-31 | $35,108 | 1,153 | Shares | Sole | 2022-03-23 | |
| No filing history on record for this holder in this stock. | ||||||